Search

everythinglearnresearchcommunity

for

Search:↓

European dermatological guidelines vary in quality, with some highly rated, but improvements are needed in applicability and consistency.

New tools and criteria have been developed to better assess and treat pediatric lupus.

The EFSUMB created basic guidelines for using ultrasound in skin-related medical practice.

The document concludes that better tools are needed to measure skin disease severity in dermatomyositis and cutaneous lupus erythematosus, and introduces the DSSI and CLASI as reliable instruments.

Abrocitinib at 100 mg and 200 mg daily may significantly improve moderate-to-severe atopic dermatitis in patients 12 years and older.

The document concludes that Cutaneous Lupus Erythematosus has different forms, is influenced by genetic and environmental factors, and can be treated with various medications, but more targeted therapies are needed.

The CLASI is a reliable tool for measuring the severity of cutaneous lupus erythematosus.

Erosive lichen sclerosus is a distinct subtype with specific skin features, and treatment led to complete resolution in half of the cases.

A new classification and scoring system is needed for alopecia areata to better assess severity.

The document concludes that a new system using the SALT score should replace the current alopecia areata classification for better accuracy in assessing severity and prognosis.

Etanercept effectively treated a severe skin condition when other treatments failed.

Skin problems are common and early signs of Systemic Lupus Erythematosus, and certain immune system markers are important for diagnosis and treatment.

New mutations in the SLC39A4 gene found in twins help understand the genetic cause of acrodermatitis enteropathica.

Lupus affects the skin in various ways, and proper skin examination is crucial for diagnosis and treatment.

Higher MPV and CRP levels may indicate more severe alopecia areata.

Congenital atrichia with papular lesions is often misdiagnosed, and new diagnostic criteria can improve accuracy.

CLASI is a valid tool for assessing skin activity and damage in lupus patients.

Consider necrolytic acral erythema in similar cases and treat with oral zinc sulfate.

Different skin diseases show unique patterns of skin cell separation, cell death, and granular layer changes.

Chronic cutaneous lupus erythematosus should be considered when acne treatments don't work.

Abrocitinib is being evaluated for safety and effectiveness in treating moderate to severe atopic dermatitis.

Skin emergency severity rises with other health issues and affects multiple organs; a new grading system can improve patient care.

Most people with systemic lupus erythematosus have skin problems, and skin symptoms are often the first sign of the disease.

Diagonal earlobe crease and lipoprotein(a) together help diagnose coronary heart disease.

Cutaneous lupus erythematosus is a chronic skin disease that can progress to systemic lupus in some cases and requires treatment to prevent recurrences and scarring.

The AAcQLI is a promising tool for assessing quality of life in children with alopecia areata.

Abrocitinib effectively treats severe alopecia areata with significant improvement and no side effects.

AUC and APL are distinct conditions needing careful clinical assessment.

Patients with certain skin symptoms and high ANA titers should be monitored for potential systemic lupus.

In Italian patients with lupus, the most common skin issue was chronic cutaneous lupus, especially discoid lesions, and nonspecific skin problems occurred in about a third of those with systemic lupus, mainly during active disease.